The impact of tenofovir in suppressing viral replication is due in part to the synergistic action of CD8+ T cells, which control replication of SIV during both acute and chronic phases of infection [17,33,34], suggesting that antiviral immunity plays a key role in determining the success of antiretroviral drugs [14]. The gene discussed is CD8A; the disease is infection.